✦ LIBER ✦

543 - Phase 1 study to investigate alternate sequencing of the combination of gemcitablne and paclitaxel in ovarian carcinoma

✍ Scribed by C.J. Poole; T. Perren; T. Hogberg; J. Cook; A.H. Jenkins; M. Ridderheim; K. Anderson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study to investigate alternate

✍ Carmichael, J.; Langley, R.; Osboume, L.; Andrews, L.; Woll, P.; Stickland, J.E. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Phase 1A/B study of combination carbopla

✍ Chon, H.; Herschberger, A.; Lee, J.; Wenham, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Paclitaxel, carboplatin and pegylated li

✍ Peter G. Rose; Benjamin E. Greer; Ira R. Horowitz; Maurie Markman; Nancy Fusco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase 1 study with weekly cisplantin/pac

✍ F. Romeo; S. Pignata; P. Frezza; S. Tramontana; F. Perrone; R. Tambaro; G. Casel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Optimized sequence of drug administratio

✍ C.J. POOLE; T. PERREN; S. GAWANDE; M. RIDDERHEIM; J. COOK; A. JENKINS; D. ROYCHO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

A Phase II Study of the MDR Inhibitor Bi

✍ Michael V. Seiden; Kenneth D. Swenerton; Ursula Matulonis; Susan Campos; Peter R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB